SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $31

Morgan Stanley maintains Avanos Medical (NYSE:AVNS) with a Underweight and raises the price target from $29 to $31.

Benzinga · 05/07/2020 11:35

Morgan Stanley maintains Avanos Medical (NYSE:AVNS) with a Underweight and raises the price target from $29 to $31.